HAUSMAN DIANA
Insider CIK 1563992 · ZYME Chief Medical Officer · ONTY Chief Medical Officer · ZNTL Chief Medical Officer, Director · IMRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMRX Immuneering Corp | A Award deriv | 2026-06-11 | 2026-06-11 | 33,350 | — | $0 | 33,350 | SEC↗ |
| IMRX Immuneering Corp | P Buy | 2025-07-02 | 2025-07-07 | 3,000 | $3.62 | $10.9K | 3,000 | SEC↗ |
| IMRX Immuneering Corp | P Buy | 2025-07-02 | 2025-07-07 | 2,500 | $3.60 | $9.0K | 2,500 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2025-06-13 | 2025-06-16 | 33,350 | — | $0 | 33,350 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2024-06-12 | 2024-06-13 | 33,350 | — | $0 | 33,350 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-05-09 | 2024-05-09 | 3,356 | $12.62 | $42.4K | 373,876 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 337,500 | — | $0 | 337,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-02-01 | 2024-02-05 | 337,500 | — | $0 | 377,232 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2023-06-14 | 2023-06-15 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2023-05-08 | 2023-05-10 | 39,732 | — | $0 | 39,732 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2022-06-21 | 2022-06-23 | 6,185 | — | $0 | 6,185 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2022-01-14 | 2022-01-18 | 25,200 | $13.00 | $327.6K | 25,200 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,500 | — | $0 | 5,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2021-03-10 | 2021-03-12 | 8,125 | — | $0 | 8,125 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2021-03-10 | 2021-03-12 | 48,750 | — | $0 | 48,750 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2021-03-10 | 2021-03-12 | 1,048 | $34.95 | $36.6K | 5,377 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2021-03-10 | 2021-03-12 | 2,500 | — | $0 | 6,425 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2021-01-07 | 2021-01-11 | 207 | $30.92 | $6.4K | 3,925 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-04 | 2020-12-04 | 3,182 | — | $0 | 47,673 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-04 | 2020-12-04 | 2,850 | — | $0 | 68,028 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-04 | 2020-12-04 | 2,850 | $9.82 | $28.0K | 6,568 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-04 | 2020-12-04 | 3,182 | $11.84 | $37.7K | 9,750 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2020-12-04 | 2020-12-04 | 6,032 | $55.12 | $332.5K | 3,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-02 | 2020-12-03 | 127 | — | $0 | 70,751 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-02 | 2020-12-03 | 574 | — | $0 | 50,281 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-02 | 2020-12-03 | 127 | $9.82 | $1.2K | 3,845 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2020-12-02 | 2020-12-03 | 701 | $55.01 | $38.6K | 3,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-02 | 2020-12-03 | 574 | $11.84 | $6.8K | 4,419 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-01 | 2020-12-03 | 14,145 | — | $0 | 50,855 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-12-01 | 2020-12-03 | 4,122 | — | $0 | 70,878 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-01 | 2020-12-03 | 4,122 | $9.82 | $40.5K | 7,840 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2020-12-01 | 2020-12-03 | 18,267 | $55.19 | $1.01M | 3,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-12-01 | 2020-12-03 | 14,145 | $11.84 | $167.5K | 21,985 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-09-14 | 2020-09-16 | 10,000 | — | $0 | 65,000 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-09-14 | 2020-09-16 | 10,000 | — | $0 | 75,000 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-09-14 | 2020-09-16 | 10,000 | — | $0 | 17,235 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2020-09-14 | 2020-09-16 | 10,000 | — | $0 | 14,702 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-09-14 | 2020-09-16 | 10,000 | $9.82 | $98.2K | 33,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-09-14 | 2020-09-16 | 10,000 | $11.84 | $118.4K | 43,718 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2020-09-14 | 2020-09-16 | 40,000 | $45.00 | $1.80M | 3,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-09-14 | 2020-09-16 | 10,000 | $17.15 | $171.5K | 23,718 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2020-09-14 | 2020-09-16 | 10,000 | $15.74 | $157.4K | 13,718 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2020-07-02 | 2020-07-06 | 367 | $30.66 | $11.3K | 3,718 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2020-03-10 | 2020-03-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2020-03-10 | 2020-03-11 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2020-01-08 | 2020-01-09 | 332 | $19.54 | $6.5K | 3,351 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2019-07-08 | 2019-07-10 | 520 | $12.49 | $6.5K | 3,019 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2019-01-08 | 2019-01-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2019-01-08 | 2019-01-10 | 499 | $12.48 | $6.2K | 2,499 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2015-06-01 | 2015-06-03 | 5,747 | $4.65 | $26.7K | 5,747 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-12-16 | 2014-12-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-12-12 | 2013-12-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2012-12-12 | 2012-12-14 | 50,000 | — | $0 | 50,000 | SEC↗ |